Genkyotex
is a biopharmaceutical company that develops and commercializes NOX therapies for fibrosis, inflammation and cancer diseases... Read moreGenkyotex
is a biopharmaceutical company that develops and commercializes NOX therapies for fibrosis, inflammation and cancer diseases... Read more
News
Oct 07, 2021
BioSpace
Genkyotex: Calliditas announces acquisition of remaining Genkyotex minority shares
Jun 22, 2021
Acrofan
Genkyotex: Genkyotex: Disclosure of the Total Number of Voting Rights and Shares Pursuant to Article L. 233-8 II of the French Commercial Code and Article 223-16
May 21, 2021
StreetInsider
Press Release: Genkyotex : Genkyotex: Disclosure of the Total Number of Voting Rights and Shares Pursuant to Article L. 233-8 II of the French Commercial Code and Article 223-16 of the General Regulation of the French Financial
May 13, 2021
MarketScreener
Genkyotex: Genkyotex : provides business update and reports cash position at March 31, 2021
Mar 02, 2021
StreetInsider
Press Release: Genkyotex : Genkyotex: Disclosure of the total number of voting rights and shares pursuant to Article L. 233-8 II of the French Commercial Code and Article 223-16 of the General Regulation of the French Financial
Feb 18, 2021
MarketScreener
Genkyotex: Genkyotex : Announces 2020 Annual Financial Results and Provides Corporate Update
Jan 27, 2021
FinanzNachrichten
Genkyotex: Genkyotex Provides Q4 Business Update and Reports Cash Position
Jan 22, 2021
MarketScreener
Genkyotex: Genkyotex : Announces Update for Near Term Clinical Development Plan for Setanaxib
Jan 19, 2021
Pharmabiz
Genkyotex: Genkyotex announces positive phase 1 data of highdose setanaxib in primary biliary cholangitis patients
Jan 12, 2021
MarketScreener
Genkyotex: Half-Yearly Report on Genkyotex's Liquidity Contract With Kepler Cheuvreux
Genkyotex Competitors
1
2
3
4
5
6
7
8
9
10